Aine Miller

Farallon Capital Management LLC (Farallon) is a SEC-registered investment advisor and hedge fund manager headquartered in San Francisco, California. The firm was founded in 1986 and is a wholly-owned subsidiary of Farallon Capital Management LP. Farallon provides administrative services and discretionary investment management services to private investment funds, the securities of which are offered to investors on a private placement basis; and to separately managed accounts for institutions such as endowments, foundations, charitable organizations and state and municipal government entities.

Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.

Elliott Management Corp. (Elliott) is a SEC-registered investment advisor and hedge fund manager headquartered in New York City. It was founded by Paul Singer in 1977. The firm is a subsidiary of Elliott Capital Advisors LP, which is owned by Paul Singer and trusts for the benefit of members of his family. Elliott provides discretionary investment advice and other services to certain private investment funds and co-investment commitments. Investors in the funds include pension plans, sovereign wealth funds, university endowments, charitable organizations, funds-of-funds, insurance companies, high net-worth individuals and families, and Elliott insiders.

Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA.

The German Marshall Fund of United States is a faith-based organization founded in 2003 by Richard L. Hamlet. The private company is based in the United States and has subsidiaries in various countries. The organization aims to connect individuals, businesses, and churches to reach the unreached world with the gospel and to minister to those in need. The American company sponsors over 40 gospel-centered evangelism, church planting, and discipleship ministries in over 30 different countries. In addition to their philanthropic efforts, GMF Capital LLC is a privately-owned alternative investment platform that invests in direct venture capital, crypto & blockchain, private equity, and real estate.

Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers.

Weiss Asset Management LP (Weiss) is an independent registered investment advisor and hedge fund manager headquartered in Boston, Massachusetts. The firm was founded by Andrew Weiss in 2003 as Weiss Capital LLC. They converted to a limited partnership and changed its name to Weiss Asset Management LP in 2010. Weiss serves as the investment manager to three privately offered pooled investment vehicles and one closed-end investment vehicle that is listed on the AIM Market of the London Stock Exchange plc.

Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC.

Part of Future Healthcare, Inc., Clinical Pharmacology Center, Inc. is a private company that specializes in clinical trial research for pharmaceuticals. The company is based in New Bedford, MA. Clinical Pharmacology Center was acquired by Future Healthcare, Inc. on July 14, 1994.

Anglo Irish Bank provides banking and other financial services. Its services include business banking, personal savings, treasury, wealth management, asset protection, corporate, expatriate and professional intermediary services. The company was founded in 1964 and is headquartered in Dublin, Ireland.

Madison Dearborn Partners LLC (Madison Dearborn Partners) is a private equity firm founded in 1992 by John A. Canning Jr., Paul J. Finnegan, Samuel M. Mencoff, Robin P. Selati, James N. Perry Jr. and Timothy P. Sullivan. The firm is headquartered in Chicago, Illinois.

Acosta, Inc. engages in the provision of sales, marketing, and retail merchandising services. Its services include business intelligence, headquarter sales, retail services, consumer marketing, Acosta solutions, and e-commerce. . The company was founded by Louis Acosta in 1927 and is headquartered in Jacksonville, FL.

StreetSquash provides long-term services for children and families. The non-profit company is based in New York, NY.

Susan G. Komen for the Cure conducts research for breast cancer treatment. It is an non-profit organization engages in breast cancer cure research and fund raising activities. The company was founded by Nancy Goodman Brinker in 1982 and is headquartered in Dallas, TX.

Retrotope, Inc. operates as clinical-stage pharmaceutical company that develops drugs to treat degenerative diseases. It offers drugs and therapies to treat Parkinson’s, Alzheimer’s, mitochondrial myopathies and retinopathies diseases. The company was founded by Charles R. Cantor, Robert J. Molinari, and Mikhail S. Shchepinov in 2006 and is headquartered in Los Altos, CA.

Theravance Biopharma US, Inc. operates as a biopharmaceutical company. The firm serves in the areas of inflammation and immunology, drug development programs, including the combination of fluticasone furoate, umeclidinium, and vilanterol. The company is headquartered in South San Francisco, CA.

Maravai Life Sciences, Inc. provides investment services. It focuses on acquiring companies and products in the diagnostics and life sciences industry. The company was founded by Carl W. Hull and Eric Tardiff in March 18, 2014 and is headquartered in San Diego, CA.

Biosplice Therapeutics, Inc. provides medical research and development for tissue-level regeneration. It develops therapeutics to address a range of degenerative diseases, regenerative medicine and oncology. The company was founded by Osman Kibar and John Hood in 2008 and is headquartered in San Diego, CA.

California Biomedical Innovation Alliance provides biomedical advocacy and community services. The private company is based in South San Francisco, CA and has subsidiaries in United States. The CEO of the company is Sara Radcliffe.

Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA.

California Life Sciences Association (CLSA) is the largest and most influential life sciences advocacy and business leadership organization in California. The non-profit company is based in South San Francisco, CA, and has offices in other locations as well. The company works closely with industry, government, academia, and others to shape public policy, improve access to innovative technologies, and grow California's life sciences economy. CLSA serves biotechnology, pharmaceutical, medical device, and diagnostics companies, research universities and institutes, investors, and service providers throughout the state. Mike Guerra has been the CEO of the company since 2019.

Praxis Bioresearch LLC is a biopharmaceutical company based in the United States. The American company is focused on the discovery and development of therapeutics for chronic neuropsychiatric and neurodegenerative disorders. Praxis's lead development candidate is PRX-P4-003, a novel prodrug stimulant designed to offer the proven clinical activity of currently marketed stimulants while reducing the risk of abuse and addiction. PRX-P4-003 is being developed for the treatment of binge eating disorder and apathy in Alzheimer's disease. Sebastián Bernales and Sandeep Patil have been the CEOs since 2014. The private company was founded in 2014 by Sebastián Bernales, Rick E. Winningham, and Sandeep Patil.

Royalty Pharma Management LLC engages in funding in the biopharmaceutical industry. The private company is located in the US.